Article Correctness Is Author's Responsibility: Successful study of Swedish vaccine candidate against diarrhea

(University of Gothenburg) University of Gothenburg reports first successful results of the oral, inactivated vaccine candidate ETVAX against enterotoxigenic E. coli diarrhea in a placebo-controlled phase I/II study in infants and children from 6 months to 5 years of age in Bangladesh.